Solventum Corporation (FRA:KB7)

Market Cap	10.79B
Revenue (ttm)	7.14B
Net Income (ttm)	323.57M
Shares Out	n/a
EPS (ttm)	1.86
PE Ratio	33.33
Forward PE	11.98
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30
Average Volume	46
Open	62.40
Previous Close	61.20
Day's Range	62.40 - 63.00
52-Week Range	54.40 - 80.50
Beta	n/a
RSI	58.65
Earnings Date	Nov 6, 2025

About Solventum

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wr...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2023
• Employees: 22,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: KB7

Financial Performance

In 2024, Solventum's revenue was $8.25 billion, an increase of 0.70% compared to the previous year's $8.20 billion. Earnings were $479.00 million, a decrease of -64.41%.

Financial numbers in USD